Hospital
Tate County Hospital
Tate County Hospital was paid $1.53M by Medicaid between May 2023 and Dec 2024, across 67 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoTATE COUNTY HOSPITAL
SENATOBIA, MS 38668
SENATOBIA, MS 38668
33aNPI1619676251assigned 03/02/2023
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.53M
24GClaims42,230
24DCodes billed67
24AFirst – last monthMay 2023 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#46 of 77
Median peer was paid$8.23M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 17,559 | $694K | |
| 2024incomplete | 24,671 | $840K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 3,034 | 2,550 | $407K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 2,337 | 1,840 | $372K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 943 | 715 | $165K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.8% | 877 | 701 | $74K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 395 | 320 | $57K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 1,698 | 1,381 | $48K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.5% | 834 | 754 | $38K |
| G0378 | Hospital observation service, per hour | 2.4% | 225 | 168 | $37K |
| 71045 | Radiologic examination, chest; single view | 2.4% | 1,207 | 921 | $36K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 545 | 425 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 1,051 | 787 | $31K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 1,396 | 1,054 | $27K |
55 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 915 | $25K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 801 | $20K |
| 87400 | 1.3% | 2,968 | $19K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 534 | $18K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 497 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.0% | 657 | $16K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 269 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 2,605 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,847 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 118 | $6K |
| 84484 | <1% | 1,152 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 131 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 68 | $5K |
| 81025 | <1% | 716 | $4K | |
| 87428 | <1% | 87 | $3K | |
| 83880 | <1% | 265 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 29 | $2K |
| 83735 | <1% | 755 | $2K | |
| 83605 | <1% | 439 | $2K | |
| 83690 | <1% | 596 | $2K | |
| 73630 | <1% | 47 | $2K | |
| 81003 | <1% | 1,656 | $2K | |
| 73610 | <1% | 33 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 72 | $2K |
| 73560 | <1% | 31 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 31 | $1K |
| 87634 | <1% | 20 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 199 | $1K |
| 85379 | <1% | 292 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 53 | $1K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 17 | $845.58 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 14 | $721.96 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 312 | $695.58 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 149 | $520.22 |
| 85610 | <1% | 326 | $456.76 | |
| 82803 | <1% | 60 | $424.35 | |
| 85732 | <1% | 139 | $315.76 | |
| 87807 | <1% | 19 | $165.18 | |
| 81001 | <1% | 81 | $128.25 | |
| 87040 | <1% | 18 | $92.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18 | $69.58 |
| 82962 | <1% | 42 | $48.21 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 785 | $36.96 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 627 | $5.50 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 18 | $4.32 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 561 | $4.32 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 54 | $1.30 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 110 | $1.06 |
| A9270 | Non-covered item or service | 0% | 4,354 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 21 | $0.00 |
| 96376 | 0% | 94 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 688 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 130 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 118 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMMONS, JOSHUA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Tate County Hospital | Senatobia, MS | $147K |
| Delta Health System | Senatobia, MS | $52K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.